Reformulating a drug that works and has a large clinical history, and spending tens of millions of dollars to dose patients over the next 4 months and 3 years is a long con indeed.
I presume Mason and DT will exit as soon as the first dose goes in, to give them some liquidity. Might be a bit hard for Dr T with near 10% of the SOI though
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
-0.015(1.21%) |
Mkt cap ! $212.8M | |||
| Open | High | Low | Value | Volume |
| $1.24 | $1.24 | $1.23 | $2.875K | 2.338K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 12660 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.23 | 9060 | 4 |
View Market Depth
| Last trade - 10.27am 27/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |